United States Of America to India: Dasatinib Import Trade Route

The United States Of America to India Dasatinib corridor is one of India's established pharmaceutical import routes from United States Of America, with 2 shipments documented worth a combined $56.6K USD. The route is dominated by AMSTERDAM PHARMA, which alone accounts for roughly 63% of all import value, reflecting the consolidated nature of United States Of America's dasatinib export sector.

Across 2 active United States Of America suppliers, the average shipment value stands at $28.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with dasatinib's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 22.1%, placing it at rank #9 among India's top dasatinib import origins globally.

On the Indian buyer side, key Indian importers include QPS BIOSERVE INDIA PRIVATE LIMITED, BIOCON PHARMA LIMITED. QPS BIOSERVE INDIA PRIVATE LIMITED is the single largest Indian importer with 1 shipments valued at $35.5K USD.

India's dasatinib imports from United States Of America are driven primarily by a handful of large-scale United States Of America manufacturers. AMSTERDAM PHARMA with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — Indian buyers benefit from United States Of America supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AMSTERDAM PHARMA, XXRMAXXND XXRMOXXOM XXOD XXDA — together account for 100% of total trade value on this route. The average shipment value of $28.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as dasatinib tablets 100 mg 100 milligram (mg) (sprycel) x 30 tablets, suggesting that Indian buyers tend to consolidate orders across related product lines from the same United States Of America supplier.

On the buying side, QPS BIOSERVE INDIA PRIVATE LIMITED is the largest importer with 1 shipments worth $35.5K USD — representing 63% of all dasatinib imports from United States Of America on this route.